Clinical Trial Update: High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating high-dose vitamin D3 supplementation in HIV-1 infection patients with vitamin D deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hypovitaminosis

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of the Punjab | Conditions: HIV-1-infection, Hypovitaminosis D | Phase 3 | Status: COMPLETED